Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007;2(4):595-607.

Lipid-based colloidal carriers for peptide and protein delivery--liposomes versus lipid nanoparticles

Susana Martins  1 , Bruno Sarmento, Domingos C Ferreira, Eliana B Souto
Affiliations
Review

Lipid-based colloidal carriers for peptide and protein delivery--liposomes versus lipid nanoparticles

Susana Martins et al. Int J Nanomedicine. 2007.

Abstract

This paper highlights the importance of lipid-based colloidal carriers and their pharmaceutical implications in the delivery of peptides and proteins for oral and parenteral administration. There are several examples of biomacromolecules used nowadays in the therapeutics, which are promising candidates to be delivered by means of liposomes and lipid nanoparticles, such as solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC). Several production procedures can be applied to achieve a high association efficiency between the bioactives and the carrier, depending on the physicochemical properties of both, as well as on the production procedure applied. Generally, this can lead to improved bioavailability, or in case of oral administration a more consistent temporal profile of absorption from the gastrointestinal tract. Advantages and drawbacks of such colloidal carriers are also pointed out. This article describes strategies used for formulation of peptides and proteins, methods used for assessment of association efficiency and practical considerations regarding the toxicological concerns.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Almeida AJ, Runge S, Muller RH. Peptide loaded solid lipid nanoparticles (SLN): influence of production parameters. Int J Pharm. 1997;149:255–65.
    1. Amselem S, Domb AJ, Alving CR. Lipospheres as a vaccine carrier system: effects of size, charge, and phospholipid composition. Vaccine. 1992;1:383–95.
    1. Anne SU. Biophysical Aspects of Using Liposomes as Delivery Vehicles. Bioscience Reports. 2002;22:129–50. - PubMed
    1. Arifin DR, Palmer AF. Determination of size distribution and encapsulation efficiency of liposome-encapsulated hemoglobin blood substitutes using asymmetric flow field-flow fractionation coupled with multi-angle static light scattering. Biotechnol Prog. 2003;19:1798–811. - PubMed
    1. Arulsudar N, Subramanian N, Mishra P, et al. Preparation, characterization, and biodistribution study of technetium-99m-labeled leuprolide acetate-loaded liposomes in ehrlich ascites tumor-bearing mice. AAPS PharmSci. 2004;6(1) Article 5. - PMC - PubMed

LinkOut - more resources